• Trending
    • Cell and Tissue Engineering
    • Organoids and Organ-on-a-chip
    • Bioprocessing
    • Stem Cells
    • Industry
    • Network
    • Projects
    • News
    • Events
    • Join
    • About us
    New post
    Sign in
    New post

    Biotechnet Projects 2019-2021: Featured in Swiss Biotech Annual Reports 2020-2022

    • Success-story
    • prev
    • next
    • Website
    • Leave a review
    • Bookmark
    • Share
    • Report
    • prev
    • next
    Description

    Since its foundation in 2001, Biotechnet has executed over 150 successful projects with industry and other research partners. Here are a few highlights from 2019-2021.

    Swiss Biotech Report 2022: Working together towards innovation that matters

    • Automated engineering and analysis of 3D-human skeletal muscle models for the investigation of potential treatments of muscle wasting diseases (ZHAW, Novartis, Innosuisse)
    • in vitro models to evaluate the interaction of Perseo’s nanomedicine with biological barriers (Perseo pharma, FHNW)
    • 3D-liver models for therapeutic antibody against liver fibrosis (Alentis Therapeutics, FHNW)
    • AI technology to label therapeutic antibodies with an imaging load (HES-SO Valais, CHUV, Debiopharm, Innosuisse)
    • Optical Blood Pressure Monitoring (OBPM) technology for hypertension (Aktiia, CSEM)
    • Platform to deliver personalized ovarian cancer therapy (AnaPath Services GmbH, FHNW, Eurostars)
    • World’s first automated machine to produce customized skin tissue grafts (CUTISS, CSEM)
    • Device to test the efficacy of antiparasitic drugs (INVENesis, INRAE, CSEM)
    • Advanced organoid technology to model host-parasite interactions (SUN bioscience, EPFL, CSEM, FHNW)
    • 3D-printed, tailor-made bioreactors for pharma and medicine: Flexibility by additive manufacturing (ZHAW, Presens, Applikon, Levitronix, Neue Materialien Bayreuth, EUROSTAR)

    Swiss Biotech Report 2021: Public-private partnerships generate prompt response to COVID-19

    • Human microphysiological systems (MPS) to better understand SARS-CoV-2 (ZHAW, FHNW)
    • POC diagnostics for tracing SARS-CoV-2 (CSEM, HES-SO)
    • Detecting COVID-19 in saliva: home‐use rapid diagnostic tests (DAVINCI consortium, CSEM, Botnar Research Centre)
    • Mass testing: PCR-based COVID-19 tests in saliva for a large number of students (FHNW, Biolytix AG, Kanton Baselland)
    • Virablock: Intelligent textiles for masks (HeiQ Materials AG, FHNW)
    • COMO Real-time remote patient monitoring (Vexatec, CSEM, EOS S.R.L)
    • Optical sensors to test for previous infection (Adamant Innotech, CSEM)
    • Talent development: Digitalization, automation and control of biotechnology processes (Lonza, HES-SO, Ibex Biopark)
    • Process development for COVID 19 VLP vaccine production (ZHAW, Saiba, University Bern)

    Swiss Biotech Report 2020: Strategic interactions for dynamic times

    • 0.3mm diameter spherical cell culture model for formation of liver fibrosis (FHNW, InSphero AG, Innosuisse)
    • Summer School on Advanced Biotechnology (University of Palermo, FHNW)
    • Summer School on Health and the Environment (FHNW, Nanjing University, China and the International Institute for Environmental Studies, Canada)
    Link
    • https://www.swissbiotech.org/report/
    Success of
    Biomonitoring
    • Industry
    • Network
    • Projects
    • News
    • Events
    • Join
    • About us

    Cart

      • Trending
      • Cell and Tissue Engineering
      • Organoids and Organ-on-a-chip
      • Bioprocessing
      • Stem Cells
      • Facebook
      • Twitter
      • WhatsApp
      • Telegram
      • LinkedIn
      • Tumblr
      • VKontakte
      • Mail
      • Copy link